Cencora Balance Sheet Health
Financial Health criteria checks 3/6
Cencora has a total shareholder equity of $1.1B and total debt of $4.7B, which brings its debt-to-equity ratio to 446.1%. Its total assets and total liabilities are $66.8B and $65.7B respectively. Cencora's EBIT is $2.9B making its interest coverage ratio 14.8. It has cash and short-term investments of $3.3B.
Key information
446.1%
Debt to equity ratio
US$4.73b
Debt
| Interest coverage ratio | 14.8x |
| Cash | US$3.31b |
| Equity | US$1.06b |
| Total liabilities | US$65.71b |
| Total assets | US$66.77b |
Recent financial health updates
Here's Why Cencora (NYSE:COR) Can Manage Its Debt Responsibly
Sep 18
Here's Why Cencora (NYSE:COR) Can Manage Its Debt Responsibly
Jun 09Cencora (NYSE:COR) Seems To Use Debt Quite Sensibly
Feb 25Is Cencora (NYSE:COR) A Risky Investment?
Nov 03We Think AmerisourceBergen (NYSE:ABC) Can Stay On Top Of Its Debt
Jun 19AmerisourceBergen (NYSE:ABC) Has A Pretty Healthy Balance Sheet
Mar 02Recent updates
Here's Why Cencora (NYSE:COR) Can Manage Its Debt Responsibly
Sep 18Cencora: Credentials To Die For, But Underlying Issues Make Case For 'Hold' Rating
Sep 18Market Participants Recognise Cencora, Inc.'s (NYSE:COR) Earnings
Jul 16Cencora: Potential Exists, But Ambiguous Valuations And Data Breach Risks Are Concerning
Jun 30Are Investors Undervaluing Cencora, Inc. (NYSE:COR) By 43%?
Jun 28Here's Why Cencora (NYSE:COR) Can Manage Its Debt Responsibly
Jun 09Do Cencora's (NYSE:COR) Earnings Warrant Your Attention?
May 21Investors Interested In Cencora, Inc.'s (NYSE:COR) Earnings
Apr 05Cencora Remains Chronically Undervalued, With Material Growth Potential
Mar 25Cencora, Inc.'s (NYSE:COR) Intrinsic Value Is Potentially 53% Above Its Share Price
Mar 18Cencora (NYSE:COR) Seems To Use Debt Quite Sensibly
Feb 25Cencora (NYSE:COR) Is Posting Promising Earnings But The Good News Doesn’t Stop There
Feb 07Cencora, Inc.'s (NYSE:COR) Business Is Yet to Catch Up With Its Share Price
Jan 05Cencora: Continued Economic Value On The Table Across All Investment Horizons
Jan 04A Look At The Fair Value Of Cencora, Inc. (NYSE:COR)
Dec 15Cencora (NYSE:COR) Is Paying Out A Larger Dividend Than Last Year
Nov 05Is Cencora (NYSE:COR) A Risky Investment?
Nov 03Cencora: New Name, Same Old Economic Leverage, Reiterate Buy
Oct 18AmerisourceBergen Corporation (NYSE:ABC) Shares Could Be 34% Below Their Intrinsic Value Estimate
Aug 01AmerisourceBergen: Great Company, Wrong Price (Rating Downgrade)
Jul 28We Think AmerisourceBergen (NYSE:ABC) Can Stay On Top Of Its Debt
Jun 19Is AmerisourceBergen Corporation (NYSE:ABC) Trading At A 28% Discount?
May 01Here's Why We Think AmerisourceBergen (NYSE:ABC) Is Well Worth Watching
Apr 10AmerisourceBergen (NYSE:ABC) Has A Pretty Healthy Balance Sheet
Mar 02AmerisourceBergen declares $0.485 dividend
Feb 01AmerisourceBergen Corporation (NYSE:ABC) Shares Could Be 25% Below Their Intrinsic Value Estimate
Jan 28AmerisourceBergen partners with pharmaceutical company Civica
Jan 23Financial Position Analysis
Short Term Liabilities: COR's short term assets ($47.3B) do not cover its short term liabilities ($53.0B).
Long Term Liabilities: COR's short term assets ($47.3B) exceed its long term liabilities ($12.7B).
Debt to Equity History and Analysis
Debt Level: COR's net debt to equity ratio (134.4%) is considered high.
Reducing Debt: COR's debt to equity ratio has increased from 145% to 446.1% over the past 5 years.
Debt Coverage: COR's debt is well covered by operating cash flow (91.1%).
Interest Coverage: COR's interest payments on its debt are well covered by EBIT (14.8x coverage).